Sequencing of two novel HLA class I null alleles, A*32:160N and B*14:113N, produced by single-nucleotide mutations.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
12 2022
Historique:
received: 11 08 2022
accepted: 15 08 2022
pubmed: 19 8 2022
medline: 19 11 2022
entrez: 18 8 2022
Statut: ppublish

Résumé

Characterization of two novel HLA class I null alleles.

Identifiants

pubmed: 35980195
doi: 10.1111/tan.14774
doi:

Substances chimiques

Nucleotides 0
HLA-B Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

629-630

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA Database. Nucleic Acids Res. 2020;48:D948-D955.
Bauer M, Kempenich J, Wadsword K, Malmberg C, Beduhn B, Dehn J. Frequencies and haplotype associations of non-expressed HLA alleles in ethnically diverse populations on the National Marrow Donor Program's be the match registry. Hum Immunol. 2020;81:580-587.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75:291-455.

Auteurs

Antonio Balas (A)

Histocompatibilidad, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.

Miguel-Ángel Moreno-Hidalgo (MÁ)

Histocompatibilidad, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.

Raquel Alenda (R)

Histocompatibilidad, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.

Félix García-Sánchez (F)

Histocompatibilidad, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.

José L Vicario (JL)

Histocompatibilidad, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH